Amplyx Pharmaceuticals, Inc. — Form D
Amplyx Pharmaceuticals, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-08-01. The offering totals $66.7M, of which $40.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-08-01
- Form: D
- Accession: 0001648627-17-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $66.7M
- Amount sold: $40.0M
- Remaining: $26.7M
- Investors: 26
- Date of first sale: 2017-07-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-291889
Issuer
- Name: Amplyx Pharmaceuticals, Inc.
- CIK: 0001648627
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 12730 High Bluff Drive #160, SAN DIEGO, CA, 92130
- Phone: 858-345-1755
Officers, directors & promoters (20)
| Name | Role | Location |
|---|
| Johan K?rdel | Director | San Diego, CA |
| Michael Grey | Executive Officer | South San Francisco, CA |
| Michael Grey | Director | South San Francisco, CA |
| Elaine Heron | Director | Ann Arbor, MI |
| Edward Mathers | Director | South San Francisco, CA |
| Paul Grint | Director | San Diego, CA |
| Anand Mehra | Director | Wayne, PA |
| Mitchell Mutz | Director | Seattle, WA |
| Mitchell Mutz | Executive Officer | Seattle, WA |
| Alan Fuhrman | Executive Officer | Carlsbad, CA |
| Karen Talmadge | Director | Redwood City, CO |
| Ciara Kennedy | Director | San Diego, CA |
| Ciara Kennedy | Executive Officer | San Diego, CA |
| Ed Mathers | Director | TIMONIUM, MD |
| Johan Kordel | Director | San Diego, CA |
| Mike Hodges | Executive Officer | San Diego, CA |
| Niall ODonnell | Director | San Diego, CA |
| Santosh Vetticaden | Director | SAN DIEGO, CA |
| Chrysa Mineo | Director | SAN DIEGO, CA |
| Jack Florio | Director | SAN DIEGO, CA |
Other filings by this issuer (4)
More